Table 2.
Regression analysis for intervention (n = 85) and control (n = 70) group
| Baseline T1 | 3 months T2 | 6 months T3 | Test-statistic (T2-T1, T3-T1) | |
|---|---|---|---|---|
| Number of participants with UI | ||||
| Intervention group |
40 |
37 |
40 |
0.66 (0.15,2.90), 0.80 (0.34,1.88) |
| Control group |
40 |
38 |
34 |
|
| Frequency incontinence episodes (Number/ 3 days); mean (sd) | ||||
| Intervention group |
8.0 (11.0) |
6.6 (9.1) |
9.0 (11.4) |
−1.71 (−5.99,2.56), 1.38 (−3.03,5.79) |
| Control group |
9.5 (11.5) |
7.4 (10.1) |
7.1 (9.6) |
|
| Physical Performance Test (0-28†); mean (sd) | ||||
| Intervention group |
17.2 (4.87) |
|
18.5 (4 14) |
3.21 (1.81,4.62), p < 0.001 |
| Control group |
15.8 (5.16) |
|
14.7 (4.27) |
|
| Health Related Quality of Life SF-12 (mental; 0-100); mean (sd) | ||||
| Intervention group |
47.0 (14.2) |
|
52.0 (10.0) |
0.07 (−4.24,4.39) |
| Control group |
46.0 (12.8) |
|
51.3 (8.5) |
|
| Health Related Quality of Life SF-12 (physical; 0-100†); mean (sd) | ||||
| Intervention group |
34.7 (12.0) |
|
38.3 (11.6) |
1.70 (−3.39,6.80) |
| Control group |
34.1 (10.1) |
|
35.0 (12.1) |
|
| Specific Quality of Life (I-QOL; 0-110†); mean (sd) | ||||
| Intervention group |
68.9 (17.9) |
|
65.7 (15.6) |
−3.30 (−10.2,3.63) |
| Control group | 62.2 (17.7) | 66.2 (15.6) | ||
*corrected for chronic status.
† Higher score indicates better performance.